John T. Roehrig

Centers for Disease Control and Prevention — United States

Medicine · Health Sciences

59h-index17.5kcitations157works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(129), Viral Infections and Vectors(109), Viral Infections and Outbreaks Research(34), Malaria Research and Control(25), Vector-borne infectious diseases(24)

Publications157 total

Genetic Adaptation by Dengue Virus Serotype 2 to Enhance Infection of Aedes aegypti Mosquito Midguts
Viruses·2022· 12 citedOpen Access
Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection
Virology·2021· 10 citedOpen Access
Virus Variation and Evolution: Mechanisms and Epidemiological Significance
2020· 22 cited
A Monoclonal Antibody Specific for Japanese Encephalitis Virus with High Neutralizing Capability for Inclusion as a Positive Control in Diagnostic Neutralization Tests
American Journal of Tropical Medicine and Hygiene·2019· 9 citedOpen Access
A DENV-2-type-specific monoclonal antibody binds to the DENV-complex-reactive antigenic site on envelope protein domain 3
Journal of General Virology·2017· 4 cited
A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease
Antiviral Research·2016· 10 citedOpen Access
Arboviruses
ASM Press eBooks·2016
Next generation dengue vaccines: A review of the preclinical development pipeline
Vaccine·2015· 49 citedOpen Access
SHORT REPORT: O’NYONG-NYONG FEVER IN WEST AFRICA
2015· 1 cited
Locking and Blocking the Viral Landscape of an Alphavirus with Neutralizing Antibodies
Journal of Virology·2014· 52 citedOpen Access
Electron Cryo-microscopy of Venezuelan Equine Encephalitis Virus TC-83 in complex with neutralizing antibody Fab 3B4C-4
2014
Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection
Virology·2014· 24 citedOpen Access
Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model
Antiviral Research·2014· 17 cited
West Nile Virus in the United States — A Historical Perspective
Viruses·2013· 117 citedOpen Access
Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain
Vaccine·2013· 28 citedOpen Access
Flavivirus Infections in Humans
Encyclopedia of Life Sciences·2013· 2 cited
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation
Vaccine·2013· 45 citedOpen Access
Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion
Virology·2013· 48 cited
Mutations in the West Nile prM protein affect VLP and virion secretion in vitro
Virology·2012· 18 citedOpen Access
A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain
Vaccine·2012· 43 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Duane J. Gubler(8), Robert S. Lanciotti(7), Grant L. Campbell(7), Alison J. Johnson(7), Lyle R. Petersen(7), Alan D.T. Barrett(6), James H. Mathews(6), Ann R. Hunt(6), Denise A. Martin(5), Nicholas Komar(4), Perry F. Smith(4), Marcelle Layton(4), Roger S. Nasci(4), Gwong‐Jen J. Chang(4), Michel L. Bunning(4), Richard M. Kinney(4), Vincent Deubel(3), Nick Karabatsos(3), Joachim Hombach(3), Richard A. Bolin(3)